NREP
NEW REPRESENTATIVE AT IB RECEIVED
30/11/2025
Voltar para busca
Dado oficial do USPTO
SARCONEOS
Sabia que essa marca já está registrada no Estados Unidos?
Antes de investir em nome, identidade e divulgação, valide risco de colisão e estratégia de registro para não perder tempo nem budget.
Active USPTO registrationTipo: VerbalEscritório: US
Snapshot rápido
SARCONEOS
ST13
US500000079207745Classe
3, 5, 42
Pedido
79207745
Registro
5398665
Diagnóstico de risco e oportunidade
Leitura executiva para decisão de naming, protocolo e monitoramento.
Situação USPTO
Active USPTO registration
Tipo de processo
Pedido e registro
Eventos registrados
37
Atualização mais recente
01/12/2025
Classificação
Registrada
Tipo de marca
Verbal
Classes Nice
3, 5, 42
Data de depósito
03/08/2016
Data de registro
13/02/2018
Data de expiração
-
Ação recomendada
Execute uma análise de colidência completa e valide classes antes de qualquer protocolo ou investimento de marca.
Próximo passo
Esses são os detalhes do processo de registro. Mesmo assim, o monitoramento constante é o que garante tranquilidade de que o seu principal ativo continue protegido.
Dados completos do processo
Campos estruturados da autoridade responsável e do histórico oficial.
Data da situação
30/08/2024
Última transação
01/12/2025
Escritório responsável
United States Patent and Trademark Office
Código da situação
709
Cadastro oficial
Principal Register
Código do desenho
4
Tipo de titular
33
Localização do titular
FR
Examinador
LE,KHANH M
Unidade examinadora
M70
Localização atual
PUBLICATION AND ISSUE SECTION
Titulares e representantes
Titulares
BIOPHYTIS, société anonyme
Representantes
Cynthia A. Moyer Fredrikson & Byron, P.A.
Classificação técnica
Classes Nice
Classe 3Classe 5Classe 42
Códigos Vienna
Sem códigos Vienna disponíveis.
Produtos e serviços
Classe 3
Soapsperfumed soapsbeauty soapsshaving soapsbath soapscosmetic soaps; perfumesessential oilscosmeticshair lotions; slimming cosmetic preparations for external use
Classe 5
Pharmaceutical products for the prevention and treatment of muscular diseasessarcopeniacachexiesgenetic muscular diseases; pharmaceutical products for the prevention and treatment of metabolic diseasesdiabetesobesity and cardiovascular diseases; dietetic substancescapsulestabletsbarssachetsliquidsjelliespowders based of amino acidsmineralsmineral saltsvitaminsproteins to prevent the oxidation of the bodythe cardiovascular diseasesto improve visionto improve the articular flexibilityto promote relaxationto strengthen the immune systems and foods for medical use; food supplements for human beings; sanitary products for medical purposesmedicinal astringentsdisinfectants for medical instrumentsmedicated body care soapsdisinfectant soapsmedicated personal soapsantifungal creams for medical usemedicated lotions for the body and shampoos without rinsingrubbing alcohol for medical usemedicated skin cleansers for medical use; medical plasters; materials for medical dressingsbandagesdressings and medical gauzesabsorbent cotton for bandagesbands and strips for bandages; material for stopping teeth and for dental impressions; disinfectants; preparations for destroying vermin; fungicides; herbicides; medicated baths preparations; sanitary padspanties or towels; chemical preparations for pharmaceutical usepreventive pharmaceutical agents for cerebral hemorrhagerelease agents of medicines in the form of edible wafers for the conditioning of pharmaceutical products in the form of powdermedicated pharmaceutical astringents; parasiticides; dietetic sugar for medical use; alloys of precious metals for dental use; dietetic substances for medical use produced by organic farming or made with goods produced by organic farmingsupplements with extracts of plants for the treatment of muscle diseasesnamely sarcopeniacachexiagenetic muscular dystrophiesmetabolic diseasesdiabetesobesity and cardiovascular diseases; food for babies
Classe 42
Evaluationsassessments and research in the fields of science and technology provided by engineers; research and development of new products for others; technical project studies in scientific and technologic fieldsfeasibility studies in the field of new technologies; technological studies in the field of pharmaceutical research and development; technical research in the field of pharmaceutical research and development; research in the field of pharmaceutical products; biologicalmedical research services; clinical research in the field of pharmaceuticals; biotechnological research; scientific research for medical purposes; computer-aided scientific research services; information relating to scientific research; preparation of reports relating to scientific research; advice relating to research and development in the therapeutic field of pharmaceuticals; providing information and data relating to medical and veterinary research and development; design and development of computers and software; installationmaintenance and updating or rental of software; programming for computers; consultancy relating to computers; conversion of computer programs and data other than physical conversion; conversion of documents from a physical medium to an electronic medium
Publicações
Histórico de despachos e eventos da marca no USPTO.
37 publicações encontradas
INNT
TOTAL INVALIDATION PROCESSED BY THE IB
05/09/2025
INTS
TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IB
16/08/2025
INPC
INVALIDATION PROCESSED
16/08/2025
INTR
TOTAL INVALIDATION OF REG EXT PROTECTION CREATED
30/04/2025
C71T
CANCELLED SECTION 71
30/08/2024
REM3
COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
13/02/2023
FINO
FINAL DECISION TRANSACTION PROCESSED BY IB
29/06/2018
FICS
FINAL DISPOSITION NOTICE SENT TO IB
17/05/2018
FIMP
FINAL DISPOSITION PROCESSED
17/05/2018
FICR
FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
13/05/2018
R.PR
REGISTERED-PRINCIPAL REGISTER
13/02/2018
GPNX
NOTIFICATION PROCESSED BY IB
09/12/2017
NPUB
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
28/11/2017
PUBO
PUBLISHED FOR OPPOSITION
28/11/2017
OPNS
NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
22/11/2017
OP2R
NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB
22/11/2017
NONP
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
08/11/2017
CNSA
APPROVED FOR PUB - PRINCIPAL REGISTER
26/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
14/10/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
14/10/2017
ERFR
TEAS REQUEST FOR RECONSIDERATION RECEIVED
14/10/2017
GNFN
NOTIFICATION OF FINAL REFUSAL EMAILED
11/10/2017
GNFR
FINAL REFUSAL E-MAILED
11/10/2017
CNFR
FINAL REFUSAL WRITTEN
11/10/2017
TEME
TEAS/EMAIL CORRESPONDENCE ENTERED
21/09/2017
CRFA
CORRESPONDENCE RECEIVED IN LAW OFFICE
20/09/2017
TROA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
20/09/2017
RFNT
REFUSAL PROCESSED BY IB
01/07/2017
RFCS
NON-FINAL ACTION MAILED - REFUSAL SENT TO IB
09/06/2017
RFRR
REFUSAL PROCESSED BY MPU
09/06/2017
RFCR
NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW
27/05/2017
MAFR
APPLICATION FILING RECEIPT MAILED
27/05/2017
CNRT
NON-FINAL ACTION WRITTEN
26/05/2017
DOCK
ASSIGNED TO EXAMINER
23/05/2017
NWOS
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
23/05/2017
REPR
SN ASSIGNED FOR SECT 66A APPL FROM IB
18/05/2017
Proteção contínua da sua marca
Seja avisado a cada novo depósito que ameace SARCONEOS ou a sua marca.
Vigilância profissional por 24 meses: monitoramos o USPTO por você e alertamos a tempo de você se opor — antes que o conflito vire prejuízo.